Unfavorable Treatment Outcome and Its Predictors Among Patients with Multidrug-Resistance Tuberculosis in Southern Ethiopia in 2014 to 2019: A Multi-Center Retrospective Follow-Up Study

References

• World Health Organization; ‎2018‎. Global tuberculosis report 2018. World Health Organization. Available from: https://apps.who.int/iris/handle/10665/274453.
   Google Scholar
• Alipanah N, Jarlsberg L, Miller C, et al. Adherence interventions and outcomes of tuberculosis treatment: a systematic review and meta-analysis of trials and observational studies. PLoS Med. 2018;15(7):e1002595. doi:10.1371/journal.pmed.1002595.29969463
   PubMed Web of Science ®Google Scholar
• WHO. Treatment guidelines for drug-resistant tuberculosis; 2016.
   Google Scholar
• WHO. The end TB strategy; 2014:1–25.
   Google Scholar
• F D. National Programmatic management of Drug resistant TB in Ethiopia Participant’s manual; 2017.
   Google Scholar
• JP KE C, Van Der Walt M, Brand J, et al. Multidrug-resistant tuberculosis treatment outcomes in relation to treatment and initial versus acquired second-line drug resistance. Clin Infect Dis. 2015;62(4):418–430. doi:10.1093/cid/civ91026508515
   PubMed Web of Science ®Google Scholar
• Patel SVNK, Alpesh PB, Shukla LK, et al. Treatment outcome among cases of multidrug-resistant tuberculosis (MDR TB) in Western India: a prospective study. J Infect Public Health. 2016;9(4):478–484. doi:10.1016/j.jiph.2015.11.01126724262
   PubMed Web of Science ®Google Scholar
• Girum T, Tariku Y, Dessu S. Survival Status and Treatment Outcome of Multidrug Resistant Tuberculosis (MDR-TB) among Patients Treated in Treatment Initiation Centers (TIC) in South Ethiopia: a Retrospective Cohort Study. Ann Med Health Sci Res. 2017;7(5):331–336.
   Web of Science ®Google Scholar
• O BM A, Krasiuk V, Rybak N, et al. Risk factors for poor multidrug-resistant tuberculosis treatment outcomes in Kyiv Oblast, Ukraine. BMC Infect Dis. 2017;17(1):1–7. doi:10.1186/s12879-016-2122-x28049444
   PubMed Web of Science ®Google Scholar
• Alene KA, Viney K, McBryde ES. Clements ACA Treatment outcomes in patients with multidrug-resistant tuberculosis in north-west Ethiopia. Trop Med Int Health. 2017;22(3):351–362. doi:10.1111/tmi.1282627978594
   PubMed Web of Science ®Google Scholar
• Ep H, Garcia-Prats AJ, Law S, et al. Treatment and outcomes in children with multidrug-resistant tuberculosis: a systematic review and individual patient data meta-analysis. PLoS Med. 2018;15(7):1–26.
   Web of Science ®Google Scholar
• Htun YM, Khaing TMM, Aung NM, et al. Delay in treatment initiation and treatment outcomes among adult patients with multidrug-resistant tuberculosis at Yangon Regional Tuberculosis Centre, Myanmar: a retrospective study. PLoS One. 2018;13:12. doi:10.1371/journal.pone.0209932
   Web of Science ®Google Scholar
• Samuels JPSA, Campbell JR, Ahmad Khan F, Johnston JC. Comorbidities and treatment outcomes in multidrug resistant tuberculosis: a systematic review and meta-analysis. Sci Rep. 2018;8(1):1–13.29311619
   PubMed Web of Science ®Google Scholar
• Gualano G, Musso M, Mosti S, et al. Putting in harm to cure: drug related adverse events do not affect outcome of patients receiving treatment for multidrug-resistant Tuberculosis experience from a tertiary hospital in Italy. PLoS One. 2019;14(2):1–14.
   Web of Science ®Google Scholar
• Tefera KT, Reta MM, Sisay MM, Tamirat KS, Akalu TY. Treatment delay and associated factors among adults with drug resistant tuberculosis at treatment initiating centers in the Amhara regional state. Ethiop BMC Infect Dis. 2019;19(1):1–8.
   Google Scholar
• Bélard S, Bootsma S, Janssen S, et al. Tuberculosis treatment outcome and drug resistance in lambaréné. Gabon Prospective Cohort Study. 2016;95(2):472–480.
   Google Scholar
• Li DGE, Shen X, Wei X. Risk factors of treatment outcomes for multi-drug resistant tuberculosis in Shanghai, 2009–2012. Procedia Environ Sci. 2016;36:12–19. doi:10.1016/j.proenv.2016.09.003
   Google Scholar
• Kibret KT, Memiah P, Biadgilign S. Treatment outcomes for multidrug-resistant tuberculosis under DOTS-Plus: a systematic review and meta-analysis of published studies. Infect Dis Poverty. 2017;6(1):1–8.28160773
   PubMed Web of Science ®Google Scholar
• Nair D, Kannan T, Tripathy JP, Harries AD, Natrajan M, Swaminathan S. Predictors of unfavourable treatment outcome in patients with multidrug-resistant tuberculosis in India Public Health Action. Public Health Action. 2017;7:1.28913171
   PubMedGoogle Scholar
• Javaid A, Masud H, Basit A, et al. Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study. Clin Microbiol Infect. 2018;24(6):612–617. doi:10.1016/j.cmi.2017.09.01228970158
   PubMed Web of Science ®Google Scholar
• Leveri TH, Mollel E, Lyamuya F, Kilonzo K. Predictors of treatment outcomes among multidrug resistant tuberculosis patients in Tanzania; 2019.
   Google Scholar
• Woldeyohannes D, Aman R, Tekalegn Y, Hailemariam Z. Predictors of time to unfavorable treatment outcomes among patients with multidrug resistant tuberculosis in Oromia region. Ethiop PLoS One. 2019;14:10. doi:10.1371/journal.pone.0224025
   Web of Science ®Google Scholar
• Bastard M, Hewison C, Hayrapetyan A, et al. Effects of treatment interruption patterns on treatment success among patients with multidrug-resistant tuberculosis in Armenia and Abkhazia. J Infect Dis. 2015;211(10):1607–1615. doi:10.1093/infdis/jiu55125312040
   PubMed Web of Science ®Google Scholar
• Alene KA, Viney K, McBryde ES, et al. Treatment outcomes of patients with multidrug-resistant and extensively drug resistant tuberculosis in Hunan Province, China. BMC Infect Dis. 2017;17(1):1–11. doi:10.1186/s12879-017-2662-828049444
   PubMed Web of Science ®Google Scholar
• El Hamdouni M, Bourkadi JE, Benamor J, Hassar M, Cherrah Y, Ahid S. Treatment outcomes of drug resistant tuberculosis patients in Morocco: multi-centric prospective study. BMC Infectious Diseases. 2019;19(1):1–7.
   Google Scholar
• Kalandarova L, Parpieva N, Saidova S, et al. Treatment outcomes and adverse reactions in patients with multidrug-resistant tuberculosis managed by ambulatory or hospitalized care from 2010–2011 in tashkent, uzbekistan. Public Health Panorama. 2016;2(1):1–116.
   Google Scholar